Skip to main content

Sickle Cell Center News

Your child will be cared for by one of the most accomplished teams of sickle cell experts in the world. We provide medical care, emotional counseling and much more. We make sure your entire family gets the support you need.

Contact us

FDA Approves Two Gene Therapies for Sickle Cell Disease

Dec 8, 2023

The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease  in patients 12 years and older with recurrent vaso-occlusive crises (VOCs). 
Jump back to top